Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...
Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.
Pre-earnings options volume in tempus AI ( TEM) Inc Class A is normal with calls leading puts 7:4. Implied volatility suggests the market is anticipating a move near 15.7%, or $11.36, after results ...
Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in ...
TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...
We recently published a list of 10 Stocks Kick Off Trading Week With Losses. In this article, we are going to take a look at ...
Pelosi's Tempus AI call options contracts tripled in value in 40 days as the healthcare firm continued its upward rally on AI ...
We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...
Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) have received an average rating of “Moderate Buy” from the twelve ...
Institutional investors bet big on Tempus AI (TEM), with massive Q4 stake increases from JPMorgan, UBS, and ARK Invest ...
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was down 4.4% during mid-day trading on Friday after an insider sold shares in the company. The stock traded as low as $71.50 and last traded at $73.34.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results